122 related articles for article (PubMed ID: 3311865)
1. The binding rate of sialic acid to serum alpha 1-acid glycoprotein in patients with chronic hepatic injury.
Ozeki T; Okada Y; Iwaki K
Gastroenterol Jpn; 1987 Aug; 22(4):448-52. PubMed ID: 3311865
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-acid glycoprotein and hepatic fibrosis.
Ozeki T; Imanishi K; Uchiyama T; Sanefuji H; Fujiwara H; Mizuno S; Tanaka N; Suzuki I
Br J Exp Pathol; 1988 Aug; 69(4):589-95. PubMed ID: 3052564
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease.
Okada Y; Shimoe T; Muguruma M; Usumoto R; Tsuji T; Jinno K; Moriwaki S; Shin S; Hakomori S
Am J Pathol; 1988 Feb; 130(2):384-92. PubMed ID: 3341453
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the inflammatory process in hepatic disorders: immunochemistry of C alpha-reactive protein and of alpha 1-acid glycoprotein].
Monnet D; Kokora G; Cisse M; Ferly-Therizol M; Moreau J; Durand G; Lonsdorfer A; Yapo AE
Bull Soc Pathol Exot; 1990; 83(1):107-13. PubMed ID: 2350838
[TBL] [Abstract][Full Text] [Related]
5. Serum glycoproteins in the liver diseases. IV. Alpha-1 acid glycoprotein level in liver cirrhosis.
Arima T; Motoyama Y; Yamamoto T; Nagata K; Kondo T
Gastroenterol Jpn; 1977; 12(2):43-6. PubMed ID: 892335
[TBL] [Abstract][Full Text] [Related]
6. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
Meijer DK; van der Sluijs P
Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
[No Abstract] [Full Text] [Related]
7. A re-evaluation of the lipid-bound sialic acid determination.
Végh Z; Kremmer T; Boldizsár M; Gesztesi KA; Szajáni B
Clin Chim Acta; 1991 Dec; 203(2-3):259-68. PubMed ID: 1777985
[TBL] [Abstract][Full Text] [Related]
8. Identification of a breast tumor-associated orosomucoid by concanavalin A affinity chromatography.
Papsidero LD; Nemoto T; Chu TM
Cancer Biochem Biophys; 1978; 3(1):15-8. PubMed ID: 121919
[TBL] [Abstract][Full Text] [Related]
9. [Serum cathepsin activity in chronic liver diseases].
Kucharz EJ; Kucharz M
Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the degree of desialylation of serum alpha 1-acid glycoprotein and alpha 1-antitrypsin.
Bordas MC; Serbource-Goguel NS; Feger JM; Maccario JM; Agneray JM; Durand GM
Clin Chim Acta; 1982 Nov; 125(3):311-8. PubMed ID: 6816486
[TBL] [Abstract][Full Text] [Related]
11. Increase of serum alpha 1-acid glycoprotein despite the decline of liver synthetic function in cirrhotics with hepatocellular carcinoma.
Falleti E; Pirisi M; Fabris C; Bortolotti N; Soardo G; Toniutto P; Gonano F; Bartoli E
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):407-11. PubMed ID: 8104507
[TBL] [Abstract][Full Text] [Related]
12. Serum alpha 1-acid glycoprotein, sialic acid, and protein binding of disopyramide in normal subjects and cardiac patients.
Chu JS; Kishion S; Nomura A; Miyazaki K
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):408-10. PubMed ID: 10322928
[TBL] [Abstract][Full Text] [Related]
13. Cytidine-5'-monophosphate-N-acetylneuraminic acid. Asialoglycoprotein sialic acid transferase activity in liver and serum of patients with juvenile hepatic cirrhosis and alpha-1-antitrypsin deficiency.
Kuhlenschmidt MS; Peters SP; Pinkard OD; Glew RH; Sharp H
Biochim Biophys Acta; 1976 Apr; 429(2):359-73. PubMed ID: 1083250
[TBL] [Abstract][Full Text] [Related]
14. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.
Marshall JS; Green AM; Pensky J; Williams S; Zinn A; Carlson DM
J Clin Invest; 1974 Sep; 54(3):555-62. PubMed ID: 4137057
[TBL] [Abstract][Full Text] [Related]
15. Hepatic binding protein: the protective role of its sialic acid residues.
Stockert RJ; Morell AG; Scheinberg IH
Science; 1977 Aug; 197(4304):667-8. PubMed ID: 877581
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the carbohydrate moiety of alpha-1-acid glycoprotein purified from human cirrhotic ascitic fluid.
Biou D; Konan D; Féger J; Agneray J; Leroy Y; Cardon P; Fournet B; Durand G
Biochim Biophys Acta; 1987 Jul; 913(3):308-12. PubMed ID: 3297164
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal reaction and serum glycoprotein concentration in chronic hepatitis and liver cirrhosis.
Fehér J; Jakab L; Józsa L; Szilvási I; Papp G
Acta Morphol Acad Sci Hung; 1975; 23(4):319-26. PubMed ID: 1234831
[TBL] [Abstract][Full Text] [Related]
18. Microheterogeneity of the carbohydrate moiety of human alpha 1-acid glycoprotein in two benign liver diseases: alcoholic cirrhosis and acute hepatitis.
Biou D; Chanton P; Konan D; Seta N; N'Guyen H; Feger J; Durand G
Clin Chim Acta; 1989 Dec; 186(1):59-66. PubMed ID: 2612011
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
[TBL] [Abstract][Full Text] [Related]
20. Drug disposition in patients with HBsAg-positive chronic liver disease.
Villeneuve JP; Thibeault MJ; Ampelas M; Fortunet-Fouin H; LaMarre L; Côté J; Pomier-Layrargues G; Huet PM
Dig Dis Sci; 1987 Jul; 32(7):710-4. PubMed ID: 3595383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
